πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 912 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7358087

Compositions and methods for enhancing immune responses mediated by antigen-presenting cel

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue Apr 15 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 10 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7355012

Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7354909

Method for rapid generation of mature dendritic cells

UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Β· Granted Tue Apr 08 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 03 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7347987

Inhibition of reactive oxygen species and protection of mammalian cells

The Regents of the University of Oklahoma Β· Granted Tue Mar 25 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7339037

Glycosylation-resistant cyanovirins and related conjugates, compositions, nucleic acids, v

The United States of America, as represented by the Department of Health and Human Services Β· Granted Tue Mar 04 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 28 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7323165

Production of pancreatic islet cells and delivery of insulin

The Regents of the University of California Β· Granted Tue Jan 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7291336

Compositions and methods for enhancing immune responses mediated by antigen-presenting cel

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Tue Nov 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7285415

Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment o

The Regents of the University of California Β· Granted Tue Oct 23 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7276352

Induction of Ξ² cell differentiation in human cells by stimulation of the GLP-1 receptor

The Regents of the University of California Β· Granted Tue Oct 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7264798

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

ONCOLYTICS BIOTECH INC. Β· Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7264820

Cancer immunotherapy using autologous tumor cells combined with cells expressing a membran

The Regents of the University of California Β· Granted Tue Sep 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 30 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7252996

Ancillary composition for the preparation of committed mature dentritic cells

I.D.M. Immuno-Designed Molecules Β· Granted Tue Aug 07 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7238673

Treatment of diseases by site-specific instillation of cells or site-specific transformati

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jul 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7226589

Treatment of diseases by site specific instillation of cells or site specific transformati

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Jun 05 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 31 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7220719

Modulation of endogenous gene expression in cells

Sangamo Biosciences, Inc. Β· Granted Tue May 22 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7220582

Stem cells that transform to beating cardiomyocytes

The United States of America as Represented by the Secretary of the Department of Health and Human Services Β· Granted Tue May 22 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7198783

Sensitization of neoplastic cells to radiation therapy with reovirus

ONCOLYTICS BIOTECH INC. Β· Granted Tue Apr 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7198788

Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing C

The Board of Regents of the University of Texas System Β· Granted Tue Apr 03 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7195911

Mammalian cells that have increased proliferative capacity

The Regents of the University of Colorado Β· Granted Tue Mar 27 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7179588

Assay for the detection of paclitaxel resistant cells in human tumors

The Board of Regents of the University of Texas System Β· Granted Tue Feb 20 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7175843

Methods for selectively stimulating proliferation of T cells

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Feb 13 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 08 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7172869

Methods for transfecting T cells

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Feb 06 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 01 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7163824

Regulation of endogenous gene expression in cells using zinc finger proteins

Sangamo Biosciences, Inc. Β· Granted Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7163806

Somatic cells with ablated PrP gene and methods of use

The Regents of the University of California Β· Granted Tue Jan 16 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 11 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted